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ABSTRACT 
Context: Due to rising demand for sleep services, there has been growing interest in 
ambulatory models of care for obstructive sleep apnea (OSA). With appropriate 
training and simplified management tools, primary care physicians (PCPs) are ideally 
positioned to take on a greater role in the diagnosis and treatment of OSA.  
Objective: To compare the clinical efficacy and cost-effectiveness of a simplified 
model of diagnosis and care for OSA in primary care relative to that in specialist 
sleep centres. 
Design: A randomised, controlled, non-inferiority study. 
Setting: Primary care practices in metropolitan Adelaide and 3 rural regions of South 
Australia and a university hospital sleep medicine centre in Adelaide, Australia. 
Patients: A total of 155 patients with OSA (identified by screening questionnaire and 
home oximetry) and Epworth Sleepiness Scale (ESS) ≥8 or resistant hypertension 
were randomised into the study between September 2008 to June 2010. 81 patients 
were randomly assigned to the primary care arm and 74 patients to the specialist 
arm. 
Interventions: Primary care management of OSA led by a PCP and community-
based nurse versus usual care in a specialist sleep centre. Treatments for OSA 
employed in both arms included continuous positive airway pressure (CPAP), 
mandibular advancement splints or conservative measures only. 
Main Outcome Measures: The primary outcome was the change in ESS after 6 
months, and was assessed for non-inferiority using an a priori determined non-
inferiority margin of -2.0 points. The ESS is scored from 0 (no daytime sleepiness) to 
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24 points (high level of daytime sleepiness). Secondary outcomes included disease-
specific and general quality of life measures, OSA symptoms, CPAP compliance, 
patient satisfaction and health care costs. 
Results: There were significant improvements in ESS scores from baseline to 6 
months in both the primary care arm (12.8 [baseline] to 7.0 [6 months], p<0.001) and 
specialist arm (12.5 to 7.0, p<0.001). Primary care management was non-inferior to 
specialist management for the mean change in ESS (5.8 vs 5.4; adjusted difference -
0.13 [lower bound of one-sided 95% confidence interval : -1.5], p=0.43) using a non-
inferiority margin of -2.0. There were no differences in secondary outcomes 
measures between groups. More patients withdrew from the study in the primary 
care arm (17 [21%] vs 6 [8%]).  
Conclusions: Among patients with OSA, treatment under a primary care model 
compared with a specialist model did not result in worse sleepiness scores. 
Trial Registration: Australian New Zealand Clinical Trials Registry, ACTRN 
12608000514303, http://www.anzctr.org.au/ 
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INTRODUCTION 
 Obstructive sleep apnea (OSA) with accompanying daytime sleepiness was 
estimated during the early 1990s to affect 2-4% of middle-aged adults1, 2.  With 
growing awareness of the public health implications of untreated disease3-6 and 
rising obesity rates that have increased the prevalence of OSA7, there has been a 
steady rise in the demand for sleep service provision in specialist centres and 
growing waiting lists for sleep physician consultation and laboratory-based 
polysomnography (PSG). As a result, there has been increasing interest in the use of 
screening questionnaires, home sleep monitoring, and auto-titrating continuous 
positive airway pressure (CPAP)8-10, and greater involvement of other health care 
professionals in providing care11.  
 
One-third of primary care patients report symptoms suggestive of OSA12.  With 
appropriate training and simplified management tools, primary care physicians 
(PCPs) and practice nurses might be ideally positioned to take on a greater role in 
OSA diagnosis and management. Several randomised controlled studies have 
shown that ambulatory management of OSA in specialist sleep centres using home 
testing and auto-titrating CPAP produce comparable patient outcomes to standard 
laboratory-based sleep study methods8-11. However, whether an ambulatory 
approach would be non-inferior in a primary care setting is unknown. The aim of this 
study was to compare the clinical efficacy of OSA management provided in primary 
care by a PCP and a community-based nurse versus currently recommended 
management in a specialist sleep centre. 
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METHODS 
Design Overview 
A randomised, controlled, non-inferiority study was conducted to compare an 
ambulatory, primary care-based management strategy for OSA versus standard care 
in a specialist sleep centre. The research protocol was approved by institutional 
research ethics committees at the Repatriation General Hospital and Flinders 
Medical Centre, South Australia and the study was registered with the Australian 
New Zealand Clinical Trials Registry (ACTRN 12608000514303). Patients and PCPs 
provided written, informed consent. 
 
Settings and Participants 
Patients aged 25 to 70 years attending a primary care consultation for any reason 
were screened for eligibility by 34 PCPs between September 2008 to June 2010. 
Participants were recruited from 4 geographical locations in South Australia 
consisting of: (1) metropolitan Adelaide (6 primary care practices; 2 community nurse 
clinics); and 3 rural regions (2) South Coast (2 primary care practices; 1 community 
nurse clinic); (3) Barossa Valley (4 primary care practices; 1 community nurse clinic) 
and (4) Riverland (4 primary care practices; 1 community nurse clinic). All patients 
were screened for moderate-severe OSA using a validated two-step method15 that 
consisted of a screening OSA50 questionnaire which, if positive (i.e. score ≥5 out of 
10 points), was followed by overnight oximetry (ApneaLink, ReMed). Inclusion 
criteria were: (1) high diagnostic likelihood of moderate-severe OSA defined as an 
OSA50 questionnaire score ≥5 and overnight 3% oxygen desaturation index 
(≥3%ODI) ≥16/hr; and (2) Epworth Sleepiness Scale (ESS)16 ≥8 or persistent 
hypertension despite ≥2 antihypertensive agents. The ESS subjectively assesses 
Archived at Flinders University: dspace.flinders.edu.au
 6 
excessive daytime sleepiness by asking patients to rate their chance of dozing off 
from 0 (would never doze) to 3 (high chance of dozing) for eight commonly-
encountered scenarios, giving a total score out of 24. A cut-off score ≥8 suggests the 
presence of at least mild daytime sleepiness. Exclusion criteria were: (1) severe 
morbid obesity (body mass index [BMI] >50kg/m2); (2) neuromuscular disease; (3) 
unstable psychiatric disease or cognitive impairment considered likely to prevent the 
patient complying with instructions, completing the study and/or managing CPAP; (4) 
hospitalisation in the previous 3 months for myocardial infarction, unstable angina, 
cardiac failure or cerebrovascular accident, or New York Heart Association Class III 
or IV symptoms; or  (5) lung disease with awake resting oxygen saturation <92%. 
Demographic and anthropometric data were collected, including gender, age, 
geographical region, weight, height, BMI, and waist circumference. 
 
Randomisation and Interventions 
Patients meeting eligibility criteria were randomised into either: (1) Primary care 
management; or (2) Specialist sleep centre management. Randomisation was 
conducted by a telephone call to a clinical trials pharmacist independent of the study, 
using a computer-generated random numbers list. 
 
 (1)  Primary care management 
Patients were managed by their PCP and a community-based nurse who 
participated in a six-hour education program on OSA and its management. The 
education program was developed and presented by sleep physicians and a 
specialist nurse from the university hospital sleep medicine centre, and accredited by 
the Royal Australasian College of General Practitioners. Patients were reviewed in-
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person by one of four nurses who held clinics at five community locations (2 nurse 
clinics in metropolitan Adelaide and 1 nurse clinic in each of the three rural regions) 
to review progress and provided with advice on managing CPAP-related side effects, 
encouraged to maintain ongoing compliance with therapy, advised to discuss 
alternative treatment options with PCPs if necessary, educated about lifestyle 
changes to improve OSA and asked to complete relevant research questionnaires. 
One nurse had 15 years of experience in a tertiary care sleep medicine service and 
managed patients at the 2 metropolitan-based clinics and the South Coast clinic. The 
other 3 nurses were newly trained in OSA management, but had worked as rural-
based practice nurses prior to their involvement (1 nurse managed patients at the 
Barossa Valley clinic and the other 2 nurses managed patients at the Riverland 
clinic). In addition to the 6 hour education program which they attended alongside 
the PCPs, the sleep training provided to the community-based nurses also involved 
5 days of in-service training with specialist nurses at the tertiary sleep centre. Home 
auto-titrating CPAP (REMstar Auto, Respironics or S8 AutoSet Spirit, ResMed) was 
used over 3 consecutive nights to determine a fixed treatment pressure based on the 
90th (REMstar Auto) or 95th (S8 AutoSet Spirit) percentile pressure. CPAP devices 
were converted to a fixed pressure mode for the remainder of the study. Patients 
were followed up by their nurse with a telephone call within two weeks of 
commencing therapy and in-person at 1, 3 and 6 months, and seen by their PCP at 3 
and 6 months. CPAP adherence was objectively recorded by each device and 
information from data cards were downloaded at 1, 3 and 6 month reviews. Although 
CPAP was considered the primary treatment, PCPs were educated about and could 
initially prescribe, or at a subsequent review, switch to alternative therapies for OSA 
if deemed appropriate, including lifestyle measures, a mandibular advancement 
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splint (MAS) or upper airway surgery. PCPs were provided with contact details of a 
dentist expert in the fashioning of mandibular advancement splints (SomnoDent 
MAS, SomnoMed Ltd, Crows Nest, New South Wales, Australia). CPAP and MAS 
were available free of charge to participants.  PCPs were advised that a sleep 
physician could be contacted for advice or to request a formal consultation.  
 
(2) Specialist sleep centre management 
Patients were referred to one of nine sleep specialists at the Adelaide Institute for 
Sleep Health, South Australia, for ongoing management. Sleep specialists had 
completed their Fellowship of the Royal Australasian College of Physicians, having 
undertaken at least 3 years of respiratory medicine training including 1 year of full-
time sleep medicine training. Sleep specialists were provided with the patient’s 
overnight oximetry trace. Further investigations, including full or split-night laboratory 
PSG, and treatment recommendations were left to the discretion of the treating 
physician. CPAP titration, if recommended, was conducted manually during 
laboratory PSG or by home auto-titration. Experienced nurses at the specialist centre 
provided support for CPAP set-up and education. The same models of CPAP 
machines were used as in the primary care arm. In-person follow-ups occurred at the 
same time points as the primary care arm. As in the primary care arm, CPAP was 
considered the primary treatment, but sleep specialists could initially prescribe, or at 
a subsequent review, switch to alternative therapies for OSA if deemed appropriate 
including lifestyle measures, a MAS or upper airway surgery. 
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Outcomes and Follow-up 
The primary outcome measure was the change in ESS from baseline to 6 months16. 
Secondary outcome measures were the Functional Outcomes of Sleep 
Questionnaire (FOSQ)17, Sleep Apnea Symptoms Questionnaire (SASQ)18, Short-
Form 36 Health Survey (SF-36)19 vitality and mental health components, CPAP 
compliance, blood pressure and weight which were measured at baseline and 6 
months. Vitality and mental health components of the SF-36 have been most 
responsive in previous CPAP studies20, 21, therefore, only changes in these two 
scores are reported. A Visit-Specific Satisfaction Questionnaire (VSQ-9)22 was also 
completed at 6 months. See online supplement for a detailed description of 
questionnaires.  
 
Statistical Analysis 
Statistical analyses were performed using STATA/IC 11.2 for Windows (StataCorp 
LP, College Station, Texas, USA). Missing values for the main outcome measures 
were replaced by multiple imputation with multivariate normal regression using 
demographic and baseline outcome data, and with creation of 10 complete data 
sets. Comparisons between groups for the mean change in ESS, FOSQ, SASQ, SF-
36, weight and blood pressure after 6 months were conducted in an intention-to-treat 
manner including all patients randomised using analysis of covariance with 
adjustment for baseline scores and region. Results for data analysed by carrying 
forward baseline observations for missing values, and by inclusion of patients with 
complete data have also been conducted as a sensitivity analysis. A Student’s t-test 
was used to evaluate for group differences in CPAP use and VSQ-9 scores. The 
difference in the mean change in ESS scores after 6 months was evaluated for non-
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inferiority of the primary care arm using an a priori determined non-inferiority margin 
of -2.0 based on past literature on minimal clinically important differences for health-
related quality of life instruments23, clinical studies which have assessed natural 
variations in ESS scores and ESS responses to placebo CPAP in OSA patients24-26, 
and consensus amongst sleep physicians in a previously published study11. For the 
non-inferiority analysis, significance testing using a one-sided p-value of 0.05 was 
used to determine the probability of rejecting the null hypothesis of inferiority. 
Statistical significance for secondary outcomes was determined using a two-sided 
alpha of 0.05. 
 
Sample size 
The study was powered to assess for non-inferiority of the primary care arm relative 
to the specialist arm in the mean change in ESS score after 6 months. A sample size 
of 138 patients (69 patients in each arm) was required for a study with 90% power 
and a Type I error of 5%, assuming a non-inferiority margin of -2.0 and a standard 
deviation of 4.0 for the change in ESS. A total of 155 patients were recruited to allow 
for potential withdrawals and loss to follow-up.  
 
Within-Trial Costs 
Within-trial sleep diagnostic and treatment costs were collected and compared 
during the 6 month follow-up for nurse consultations, PCP and sleep physician 
consultations, travel costs, sleep study costs and treatment-related costs. Within-trial 
costs were also calculated for the US context and reported in US dollars. See online 
supplement for a detailed description of how costs were calculated. 
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RESULTS 
A flow diagram outlining the recruitment and randomisation pathway is shown in 
Figure 1. 402 patients were referred by PCPs after initial screening to community-
based nurses for review of eligibility criteria and oximetry monitoring. 301 patients 
agreed to and were eligible for overnight oximetry. 155 patients were found to have a 
≥3%ODI ≥16/hr and were randomised into the study.  
 
Baseline Characteristics 
81 patients (Adelaide n=27; South Coast n=3; Barossa Valley n=24; Riverland n=27) 
were randomised to the primary care arm, and 74 patients (Adelaide n=18; South 
Coast n=1; Barossa Valley n=26; Riverland n=29) to the specialist arm. The two 
groups were comparable and consisted of predominantly middle-aged, obese males 
from rural regions with at least mild daytime sleepiness (Table 1). 
 
Treatment 
The principal treatment recommended to patients at baseline and used at 6 months 
are outlined in Table 2. At baseline, almost all patients (90%) in the primary care arm 
were commenced on CPAP. Fewer patients in the specialist arm were commenced 
on CPAP (70%) and a higher proportion of patients were managed with conservative 
measures only. In the specialist arm, 73 of 74 patients had a laboratory-based full 
(n=38) or split-night (n=35) PSG. Three (4%) patients in the primary care arm were 
referred for sleep specialist consultation during the study, one of whom had a 
laboratory full night diagnostic PSG. 
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After 6 months follow-up, the proportions of patients using CPAP were similar in the 
primary care and specialist arms (63% and 61%, respectively). More patients 
withdrew from the study in the primary care arm.  Baseline demographic, 
anthropomorphic and OSA severity indices were similar in patients who withdrew 
and those who completed the study in each study arm (see eTable 1 in the online 
supplement).  
 
Outcomes 
Daytime Sleepiness: Epworth Sleepiness Scale (ESS) 
The mean ESS for the entire study population was 12.6 (95%CI: 12.0 to 13.3). There 
were significant improvements in the mean ESS scores from baseline to 6 months in 
both the primary care arm (12.8 [baseline] to 7.0 [6 months], adjusted mean 
difference 5.8 [95%CI: 4.4 to 7.2], p<0.001) and specialist arm (12.5 to 7.0, adjusted 
mean difference 5.4 [95%CI: 4.2 to 6.6], p<0.001), see Table 3). After controlling for 
baseline ESS and region, the adjusted difference in mean change in ESS was -0.13 
(lower bound of one-sided 95%CI: -1.5, p=0.43).  Sensitivity analyses using baseline 
observations carried forward for missing values and using data only from patients 
who completed the study produced similar outcomes. For the analysis using baseline 
observations carried forward for missing data, the adjusted difference in mean 
change in ESS was -0.63 (lower bound of one-sided 95%CI: -1.80, p=0.19). When 
including only patients who completed the study (primary care arm, n=64; specialist 
arm, n=68), the adjusted difference in the mean change in ESS was -0.14 (lower 
bound of one-sided 95%CI: -1.28, p=0.42). These results support non-inferiority of 
primary care management as the lower bound of the one-sided 95% confidence 
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interval for all analyses were greater than the pre-specified non-inferiority margin of -
2.0. 
 
Secondary Outcomes 
Secondary outcomes measures are shown in Table 4. After 6 months, there were 
significant improvements in the mean FOSQ, SASQ or SF-36 scores in both primary 
care and specialist groups compared to baseline (p<0.001 for all measures), but no 
difference was evident between groups.  
 
CPAP compliance in patients using CPAP at 6 months was no different between the 
two groups, with mean usage of 4.8 ± 2.1 hours per night in the primary care arm 
(n=51) and 5.4 ± 0.3 hours per night (n=44) in the specialist arm (p=0.11). No 
differences in systolic or diastolic blood pressure, or weight were evident in either 
primary care or specialist arms after 6 months, and there was no difference between 
groups in the mean change. There were small, but statistically significant, differences 
in 5 out of 9 items in the VSQ-9 patient satisfaction survey in favour of the primary 
care arm (see eTable 2 in the online supplement) although no difference in overall 
satisfaction was evident. Furthermore, effect sizes for the 9 items were small (range 
0.14 to 0.41) and may not therefore be clinically significant. 
 
Within-Trial Costs 
Comparison of within-trial sleep diagnostic and treatment costs revealed a total 
average cost per randomised patient of AUS$1606.48 in the primary care arm and 
AUS$2576.47 in the specialist arm (see eTable 3 in the online supplement). When 
considered in the US context, the equivalent total average costs per patient were 
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estimated at US$1819.44 in the primary care arm and US$3067.86 in the specialist 
arm. Sleep study costs, sleep physician consultations and travel costs appeared to 
be the main contributors to the increased within-trial costs in the specialist arm. 
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COMMENTS 
In this study, patients identified by a two-step screening process as having a high 
likelihood of moderate-severe OSA and who were at least mildly sleepy, were 
randomised to either primary care or specialist management. Clinically significant 
improvements in the primary outcome measure, daytime sleepiness, were observed 
following treatment in both settings27 and outcomes for patients managed in primary 
care were not inferior to those treated in a specialist centre. No differences between 
groups were found in secondary outcomes, including change in OSA symptoms, 
quality of life, CPAP adherence and overall patient satisfaction. 
 
These results extend the findings of previously published studies of ambulatory 
models of care for OSA deployed in specialist sleep centres. Mulgrew et al8 utilised a 
strategy of portable monitoring and auto-titrating CPAP and found no differences in 
major outcomes, including change in ESS and quality of life, compared to laboratory-
based care. Furthermore, CPAP adherence was higher in the ambulatory care arm. 
Berry et al9 conducted a similar study in a veteran population where patients with 
OSA were randomised to either portable monitoring and auto-titrating CPAP, or to 
laboratory PSG and CPAP titration. After 6 weeks, no differences were observed in 
CPAP compliance, change in ESS or FOSQ scores, patient satisfaction with CPAP 
or residual AHI. Kuna et al10 found that functional outcomes and CPAP adherence 
were not inferior to laboratory-based care when using an ambulatory strategy for 
OSA. None of these studies assessed the relative costs of the simplified 
management strategies. 
 
More recent studies evaluating ambulatory strategies for OSA have examined within-
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study costs. Andreu et al28 randomised patients into either: (1) home sleep 
monitoring and follow-up; (2) hospital PSG and follow-up; or (3) home monitoring 
and hospital follow-up. They found no differences in CPAP compliance, ESS, FOSQ 
or symptom scores after 6 months. They also reported significant cost savings for 
home diagnosis and follow-up (mean €590 ± SD 43) and home diagnosis with 
hospital follow-up (€644 ± 93) compared to laboratory PSG and hospital follow-up 
(€849 ± 11). Rosen et al29 showed that home diagnosis and auto-titrating CPAP was 
associated with higher CPAP adherence, similar to the study by Mulgrew et al, with 
no difference in the change in ESS or functional outcomes after 3 months compared 
to laboratory-based management. Within-trial costs were 25% cheaper in the home 
treatment arm. 
 
We previously conducted a randomised controlled trial to evaluate a simplified model 
of care for OSA led by sleep-trained nurses in a tertiary care setting11. The primary 
outcome, mean change in ESS at 3 months, for patients managed using the nurse-
led approach was not inferior to specialist-led management and had within-study 
cost savings of AUD$1,111 per patient. These results led us to consider the potential 
role of primary care physicians and nurses in the diagnosis and management of 
OSA. 
 
The present study which recruited patients from metropolitan and rural communities 
had a longer period of follow-up than previous studies (i.e. 6 months compared to 1-
3 months). We believe that important elements in the success of the study were the 
training given to PCPs and nurses and access to specialist support. Thus, while 
PCPs and community nurses were encouraged to take primary responsibility for 
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patient management, this simplified strategy was designed as a “hub-and-spoke”-like 
model of care, with a central specialist sleep centre overseeing and supporting a 
number of primary care-based OSA clinics. Of note though is that PCPs cross-
referred only 3 of 81 (4%) patients to sleep specialists for a second opinion. This 
could be because two-thirds of the study population were recruited in rural regions 
located 90 to 240km from the city-based specialist sleep service. However, only 1 
out of 21 (5%) metropolitan-based patients enrolled in the primary care arm were 
cross-referred suggesting perhaps that, at least in the context of the research study, 
PCPs and nurses were reasonably confident in their management decisions.     
 
At baseline, CPAP was recommended more frequently in the primary care arm. 
However, by 6 months a considerable number of patients in the primary care arm 
had stopped using CPAP, and the proportion of patients on CPAP was similar to the 
specialist arm. Average daily CPAP use at 6 months was no different between arms. 
These observations could suggest that specialists, who have additional information 
from laboratory PSG and are more experienced at OSA management, may be better 
at predicting which patients will adhere to CPAP in the long term. Alternatively, 
attendance at a specialist and/or nurse review in a tertiary sleep centre may itself 
have had an influence on long term adherence. There could also be an effect of 
experience such that with time, the PCPs may become more confident with 
managing sleep apnea and thus promote greater CPAP adherence, or recommend 
alternative therapies such as a MAS or conservative measures earlier in the course 
of treatment for patients who are reluctant to use or are intolerant of CPAP. 
However, it is interesting to note that, in spite of the different approaches to 
management, patient outcomes were ultimately similar in the two arms.  
Archived at Flinders University: dspace.flinders.edu.au
 19 
 
Analysis of within-trial sleep-related diagnostic and treatment costs revealed that 
primary care management of OSA was approximately 40% cheaper than specialist 
care in both the Australian and US contexts. However, our study reports within-trial 
sleep management-related costs only and not indirect costs nor does it assess the 
longer term economic implications of an ambulatory strategy in primary care. Recent 
debate has been sparked by a study by Pietzsch et al30 which showed full-night PSG 
to be more cost-effective than unattended home monitoring in the management of 
OSA, due to its superior diagnostic accuracy. It was pointed out in an accompanying 
editorial31, however, that several assumptions used in their modelling could have 
magnified the effects of false positive and negative results and elevated the costs of 
portable monitoring.  More detailed cost-effectiveness analyses which take into 
account increased access and reduced waiting lists, the impact of false positive and 
negative tests, potential adverse health consequences of untreated disease and 
benefits of therapy, and indirect costs of ambulatory, primary care-based 
management strategies for OSA are needed. 
 
Several limitations of our study are acknowledged. We excluded patients with a 
BMI>50kg/m2, significant respiratory or cardiac disease, and serious psychiatric 
illness or cognitive impairment. Thus, the results of this study cannot be generalised 
to these populations. It is possible that patients with predominantly central sleep 
apnea, including Cheynes Stokes respiration, may have been misdiagnosed in the 
primary care arm, since only oximetry was used to identify patients with disease. 
However, we excluded patients with disorders prone to central sleep apnea (e.g. 
heart failure) plus residual AHI was monitored on CPAP devices and, at 6 months, 
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only 1 patient in the primary care arm had a residual AHI exceeding 15/hr. 
 
One of the community-based nurses in the primary care arm who predominantly 
managed patients in the metropolitan region had 15 years of prior experience in a 
tertiary care sleep medicine service whilst the other three rural-based community 
nurses were newly-trained in OSA management. The more experienced nurse was 
included in the primary care arm to assist in the training and to mentor the newly 
recruited nurses. We would anticipate that if such a model of care were to be 
translated into real practice, that some nurses employed to manage OSA patients in 
a community-based clinic would likely have some prior experience in OSA 
management, particularly in the metropolitan region where there is a larger pool of 
experienced, CPAP-trained nursing staff. The more experienced nurse managed a 
total of 30 (37%) patients in the primary care arm who were based in the 
metropolitan and rural South Coast regions, whilst the three less experienced nurses 
managed the other 51 (63%) patients located in the rural Barossa Valley and 
Riverland regions. We have attempted to account for the difference in nurse 
experience by adjusting for geographical region in addition to baseline ESS in our 
analyses. Furthermore, withdrawal rates, change in ESS from baseline to 6 months, 
6 month CPAP adherence and auto-CPAP titration results were not  significantly 
different between the experienced versus newly-trained nurses. Therefore, we do not 
believe that inclusion of an experienced nurse in the primary care arm significantly 
biased our results. 
 
For reasons which are not entirely clear, more patients withdrew from the primary 
care arm. It is possible that patients were more inclined to remain in the study if they 
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were receiving specialist consultations. Alternatively, participants may have had less 
faith in the advice of the primary care team and the greater number of withdrawals in 
the primary care arm may be because PCPs were less skilled in educating patients 
about OSA and treatment options. Although overall patient satisfaction was no 
different between groups, the opinions of patients who withdrew were not sampled. 
Interestingly, one-half of patients who withdrew from the primary care arm did so 
because of “CPAP intolerance” whilst this was not cited as a reason in the specialist 
group. The higher number of withdrawals in the primary care arm may have biased 
study results by excluding data from patients with worse outcomes. However, we 
believe our findings are robust since in both the primary analysis using multiple 
imputation for missing values and in two sensitivity analyses, patient outcomes in the 
primary care arm remained clinically non-inferior. 
 
In conclusion, this prospective, randomised controlled study demonstrates that a 
simplified management strategy for OSA based in primary care is not clinically 
inferior to standard care in a specialist sleep centre and can likely be delivered at a 
lower cost. Thus, with adequate training of PCPs and practice nurses and 
appropriate funding models to support an ambulatory strategy, primary care 
management of OSA has the potential to improve patient access to sleep services. 
This would be particularly beneficial for rural and remote regions, as well as 
developing nations, where access to specialist services can be limited. However, 
some caution needs to be exercised in extrapolating these findings to actual practice 
where PCPs may not be as skilled and motivated as the PCPs who participated in 
this randomised controlled trial and where, conceivably, patient outcomes may not 
be as good as those observed in this study. Our comparison of within-trial costs 
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cannot be considered a cost-effectiveness analysis and further investigation is 
needed in this regard. 
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Figure 1.  Flow diagram of participant recruitment and randomisation 
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Table 1. Baseline characteristics of patients in primary care and specialist 
arms 
 
 Model A: Primary Care Arm 
(n=81) 
Model B: Specialist Arm 
(n=74) 
Males, n (%) 69 (85%) 57 (77%) 
Age, years 57.2 ± 10.9 54.5 ± 11.8 
Region 
Metropolitan, n (%) 
South Coast, n (%) 
Riverland, n (%) 
Barossa Valley, n (%) 
 
21 (33%) 
3 (4%) 
27 (33%) 
24 (30%) 
 
18 (24%) 
1 (1%) 
29 (39%) 
26 (35%) 
BMI, kg/m
2
 33.1 ± 5.5 33.7 ± 5.6 
Waist circumference, cm 111.2 ± 13.6 113.1 ± 14.5 
OSA50 questionnaire score 8.2 ± 1.5 8.1 ± 1.7 
ESS total score 12.8 ± 3.9 12.5 ± 3.9 
ApneaLink ≥3%ODI, events/hr 32.7 ± 18.2 35.7 ± 17.4 
 
Data are presented as mean ± SD or n (%) 
BMI = body mass index; ESS = Epworth Sleepiness Scale; ≥3%ODI = 3% oxygen desaturation index 
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Table 2. Principal treatment recommended to patients at baseline and used at 
6 months 
 
Recommended at Baseline: 
 
 
Principal treatment 
Model A: Primary care 
(n=81) 
Model B: Specialist sleep 
centre (n=74) 
CPAP 73 (90%) 52 (70%) 
Conservative measures only 2 (2%) 18 (24%) 
MAS 1 (1%) 3 (4%) 
Patient withdrew 5 (7%) 1 (1%) 
 
Used at 6 months: 
 
 
Principal treatment 
Model A: Primary Care 
(n=64*) 
Model B: Specialist sleep 
centre (n=68**) 
CPAP 51 (63%) 45 (61%) 
Conservative measures only 7 (9%) 12 (16%) 
MAS 6 (7%) 11 (15%) 
 
Data is presented as n (%) 
CPAP = continuous positive airway pressure; MAS = mandibular advancement splint 
*At 6 months, 17 patients had withdrawn from primary care arm 
**At 6 months, 6 patients had withdrawn from specialist arm 
Archived at Flinders University: dspace.flinders.edu.au
 Table 3. Change in Epworth Sleepiness Scale score at 6 months 
 
 Model A: 
Primary Care Arm  
(n=81) 
Model B: 
Specialist Arm  
(n=74) 
 
  
 
Mean (95%CI) 
 
 
Mean  (95%CI) 
†
Adjusted 
difference in 
mean change 
 
††
p 
value 
Lower bound 
of one-sided 
95% CI 
Baseline ESS 12.8 (12.0 to 13.6) 12.5 (12.4 to 13.5)    
6 month ESS* 7.0 (6.0 to 8.0) 7.0 (6.0 to 8.0)    
Change in ESS 5.8** (4.4 to 7.2) 5.4** (4.2 to 6.6) -0.13 0.43 -1.50 
 
ESS = Epworth Sleepiness Scale; 95%CI = 95% confidence interval  
*Missing values replaced by multiple imputation 
**p<0.001 for paired t-test comparison of ESS examining change from baseline to 6 months. 
†Based on analysis of co-variance with adjustment for baseline ESS and region. 
††1-sided p value 
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 Table 4. Secondary outcome measures at 6 months 
 
 
 
Primary Care Arm Specialist Arm 
 
 
  
n 
 
Baseline (95%CI) 
Mean change at 6 
months (95%CI) 
 
n 
 
Baseline (95%CI) 
Mean change at 6 
month (95%CI) 
*Adjusted 
difference in mean 
change (95%CI) 
 
p value 
FOSQ 81 14.7 (14.1 to 15.4) 2.8 (2.0 to 3.6) † 74 14.2 (13.5 to 14.8) 2.8 (2.2 to 3.4) † 0.18 (-0.58 to 0.94)  0.64 
SASQ  81 71.2 (66.5 to 75.9) -29.7 (-23.0 to -36.4) † 74 72.1 (67.4 to 76.7) -31.2 (-23.8 to -38.6) † 0.78 (-7.22 to 8.78) 0.85 
SF-36 vitality  81 43.6 (39.1 to 48.1) 16.1 (11.0 to 21.2) † 74 34.6 (30.3 to 38.9) 19.9 (14.4 to 25.4) † 2.51 (-3.88 to 8.90) 0.44 
SF-36 mental health  81 66.5 (62.4 to 70.7) 7.9 (4.0 to 11.8) † 74 61.6 (57.2 to 66.1)  8.4 (4.5 to 12.3) † 1.57 (-3.41 to 6.55) 0.54 
Systolic BP, mmHg 81 134.0 (130.3 to 137.8) -2.2 (-6.3 to 1.9) 74 135.9 (132.1 to 139.7) -4.4 (-9.1 to 0.3) 1.52 (-4.14 to 7.18) 0.60 
Diastolic BP, mmHg 81 84.5 (82.0 to 86.9) -1.4 (-4.3 to 1.5) 74 85.23 (82.7 to 87.8) -0.5 (-3.6 to 2.6) -1.32 (-4.97 to 2.33) 0.48 
Weight, kg 81 101.9 (97.9 to 105.9) -0.1 (-2.5 to 2.3) 74 103.2 (98.9 to 107.5) 0.3 (-1.5 to 2.1) -0.43 (-3.43 to 2.57) 0.78 
 
FOSQ = Functional Outcomes of Sleep Questionnaire – measures disease-specific quality of life by assessing the impact of daytime sleepiness on activities of daily living, 
total score out of a possible 20 points with higher scores indicating higher levels of functioning. 
SASQ = Sleep Apnea Symptoms Questionnaire – measures the frequency of 14 commonly reported OSA symptoms on a 10cm visual analogue scale, total score out of a 
possible 140 points, with higher scores indicating greater severity of OSA symptoms. 
SF-36 = Short Form 36 Health Survey – measures the general health status of a patient using 8 subscales which each have a total score out of a possible 100 points, with 
higher scores indicating a higher level of functioning. Only 2 of the 8 SF-36 subscales (i.e. vitality and mental health) are reported here. 
BP = blood pressure; BMI = body mass index; 95%CI = 95% confidence interval 
*Based on analysis of covariance with adjustment for baseline measure and region. 
†p<0.001 for paired t-test comparison of outcome measures examining change from baseline to 6 months 
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